Dolby Laboratories
(DLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 793,361 | 577,752 | 817,966 | 628,371 | 1,233,032 |
| Marketable Securities | 703 | 0 | 139,148 | 189,213 | 38,839 |
| Receivables | 331,096 | 315,465 | 262,245 | 243,593 | 232,609 |
| Inventories | 30,424 | 33,728 | 35,623 | 23,549 | 10,965 |
| Other current assets | 180,804 | 197,478 | 182,130 | 176,093 | 182,316 |
| TOTAL | $1,388,261 | $1,194,417 | $1,487,804 | $1,310,894 | $1,760,498 |
| Non-Current Assets | |||||
| PPE Net | 470,608 | 479,109 | 481,581 | 513,481 | 534,381 |
| Investments And Advances | 80,205 | 89,267 | 97,812 | 102,514 | 62,819 |
| Intangibles | 926,957 | 967,722 | 575,836 | 477,412 | 463,584 |
| Other Non-Current Assets | 361,729 | 379,413 | 336,733 | 285,247 | 284,405 |
| TOTAL | $1,839,499 | $1,915,511 | $1,491,962 | $1,378,654 | $1,345,189 |
| Total Assets | $3,227,760 | $3,109,928 | $2,979,766 | $2,689,548 | $3,105,687 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,840 | 17,380 | 20,925 | 14,171 | 17,779 |
| Accrued Expenses | 369,256 | 347,529 | 351,399 | 230,237 | 262,728 |
| Other current liabilities | 31,382 | 31,644 | 31,505 | 18,588 | 18,473 |
| TOTAL | $437,790 | $417,836 | $422,226 | $277,518 | $315,717 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 156,550 | 202,708 | 184,368 | 161,199 | 178,142 |
| TOTAL | $158,024 | $205,199 | $185,356 | $161,010 | $185,738 |
| Total Liabilities | $595,814 | $623,035 | $607,582 | $438,528 | $501,455 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,506 | 95,436 | 95,276 | 95,958 | 101,161 |
| Common Shares | 94 | 94 | 94 | 94 | 100 |
| Retained earnings | 2,634,980 | 2,496,255 | 2,391,990 | 2,297,730 | 2,607,909 |
| Other shareholders' equity | -3,128 | -9,456 | -19,900 | -46,804 | -3,777 |
| TOTAL | $2,631,946 | $2,486,893 | $2,372,184 | $2,251,020 | $2,604,232 |
| Total Liabilities And Equity | $3,227,760 | $3,109,928 | $2,979,766 | $2,689,548 | $3,105,687 |